Corsica Health Tirzepatide Review: Cost & Honest Verdict (2026)

This review attempted to independently verify Corsica Health directly against joincorsica.com and could not this check: the site returned a rate-limit response. Everything below is rather than a live reconfirmation.

Live verification was rate-limited

This review attempted to independently confirm Corsica Health's current pricing and program details directly against joincorsica.com. The site returned a rate-limit response, blocking automated verification this check. Every figure below was last verified on July 20, 2026. Visit joincorsica.com directly to confirm current terms before committing.

What Corsica Health is

Corsica Health is a telehealth platform, offering both compounded GLP-1s and brand-name FDA-approved injections through a structured 3-step flow: Assessment, Provider Review, Receive Medication. It's LegitScript certified.

What Corsica Health costs

Compounded semaglutide runs $199/month and compounded tirzepatide $249/month on a 3-month plan — competitively priced for this category. Notably, Corsica Health also publishes brand-name pricing openly: $1,499/month for brand Wegovy, Ozempic, or Mounjaro — below typical retail cash-pay rates for those products, a genuine transparency advantage most compounded-focused competitors don't offer.

The brand-vs-compounded question

Corsica Health offers both compounded tirzepatide and a genuine brand-name pathway — a real choice if brand access matters to you. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials; brand tirzepatide is the exact molecule and dose that was. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Corsica Health's real strengths: public pricing shown for both compounded and brand-name options — a genuine transparency advantage — brand-name pricing below typical retail, LegitScript certification, and a clear 3-step intake flow. The trade-offs: the legal entity name and state of incorporation aren't disclosed, the pharmacy partner is described only generically rather than named, per-state availability isn't listed publicly, and first-month promotional pricing isn't disclosed. As with any GLP-1 program, and especially one this review couldn't independently verify live, confirm your state's coverage and the specific pharmacy directly before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Corsica Health's dual public pricing for both compounded and brand-name options is a genuine transparency advantage but this review couldn't independently verify any of it live, and its pharmacy partner remains unnamed. For a provider this review could independently verify live with a similar dual pathway, compare Concierge MD LA or Bioverse. Another dual compounded-and-brand provider this review is Genesis Health. See our best tirzepatide providers ranking for the full field.